http://www.legislation.gov.uk/nisr/2012/212/madeThe Misuse of Drugs (Designation) (Amendment) Order (Northern Ireland) 2012Drugs use and abusePublic order, justice and rightsenGovernment Printer for Northern Ireland2020-04-16DANGEROUS DRUGSSection 7(3) of the Misuse of Drugs Act 1971 requires regulations to be made to allow the use for medical purposes of the drugs which are subject to control under that Act. Section 7(3) does not apply to any drug designated by order under section 7(4) as a drug to which section 7(4) is to apply. This Order amends the Misuse of Drugs (Designation) Order (Northern Ireland) 2001 by inserting into Part 1 of the Schedule to that Order desoxypipradrol and other pipradrol-related compounds.Statutory Rules of Northern Ireland2012 No. 212Dangerous DrugsThe Misuse of Drugs (Designation) (Amendment) Order (Northern Ireland) 2012Made22nd May 2012Coming into operation13th June 2012

The Department of Health, Social Services and Public Safety makes the following Order in exercise of the powers conferred by section 7(4) of the Misuse of Drugs Act 1971

1971 c.38

as adapted by section 7(9) of that Act and now vested in it

S.R & O. (N.I).1973 No.504, Article 5(a) and S.I. 1999 No.283(N.I.1);Article 3(6)

 and after consultation with the Advisory Council on the Misuse of Drugs in accordance with section 7(7) of that Act.

Citation and commencement1.

This Order may be cited as the Misuse of Drugs (Designation) (Amendment) Order (Northern Ireland) 2012 and shall come into operation on 13th June 2012.

Interpretation2.

The Interpretation Act (Northern Ireland) 1954

1954 c.33 (N.I)

shall apply to this Order as it applies to an Act of the Assembly

Amendment of the Misuse of Drugs (Designation) Order (Northern Ireland) 20013.

In Part 1 of the Schedule to the Misuse of Drugs (Designation) Order (Northern Ireland) 2001

S.R.2001 No.431:The relevant amending Orders are S.R.2005 No.359, S.R.2009 No.389 and S.R.2010 Nos. 149 and 246

after paragraph 1(r), insert—(s)

Any compound (not being pipradrol) structurally derived from piperidine, pyrrolidine, azepane, morpholine or pyridine by substitution at a ring carbon atom with a diphenylmethyl group, whether or not the compound is further modified in any of the following ways, that is to say,

(i)

by substitution in any of the phenyl rings to any extent with alkyl, alkoxy, haloalkyl or halide groups;

(ii)

by substitution at the methyl carbon atom with an alkyl, hydroxyalkyl or hydroxy group;

(iii)

by substitution at the ring nitrogen atom with an alkyl, alkenyl, haloalkyl or hydroxyalkyl group.

.

Sealed with the Official Seal of the Department of Health, Social Services and Public Safety on 22nd May 2012

(L.S.)Norman MorrowA senior officer of the Department of Health, Social Services and Public SafetyEXPLANATORY NOTE(This note is not part of the Order)

Section 7(3) of the Misuse of Drugs Act 1971 requires regulations to be made to allow the use for medical purposes of the drugs which are subject to control under that Act. Section 7(3) does not apply to any drug designated by order under section 7(4) as a drug to which section 7(4) is to apply. This Order amends the Misuse of Drugs (Designation) Order (Northern Ireland) 2001 by inserting into Part 1 of the Schedule to that Order desoxypipradrol and other pipradrol-related compounds.